StocksFundsScreenerSectorsWatchlists
BDX

BDX - Becton Dickinson and Co Stock Price, Fair Value and News

230.99USD-3.73 (-1.59%)Delayed

Market Summary

BDX
USD230.99-3.73
Delayed
-1.59%

BDX Stock Price

View Fullscreen

BDX RSI Chart

BDX Valuation

Market Cap

66.7B

Price/Earnings (Trailing)

53.13

Price/Sales (Trailing)

3.42

EV/EBITDA

18.6

Price/Free Cashflow

25.05

BDX Price/Sales (Trailing)

BDX Profitability

EBT Margin

7.90%

Return on Equity

4.96%

Return on Assets

2.4%

Free Cashflow Yield

3.99%

BDX Fundamentals

BDX Revenue

Revenue (TTM)

19.5B

Rev. Growth (Yr)

2.62%

Rev. Growth (Qtr)

-7.49%

BDX Earnings

Earnings (TTM)

1.3B

Earnings Growth (Yr)

-44.79%

Earnings Growth (Qtr)

160.19%

Breaking Down BDX Revenue

Last 7 days

-6.0%

Last 30 days

-2.4%

Last 90 days

-1.4%

Trailing 12 Months

-9.9%

How does BDX drawdown profile look like?

BDX Financial Health

Current Ratio

1.08

Debt/Equity

0.56

Debt/Cashflow

0.24

BDX Investor Care

Dividend Yield

1.59%

Dividend/Share (TTM)

3.68

Shares Dilution (1Y)

1.76%

Diluted EPS (TTM)

4.2

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202318.8B19.0B19.4B19.5B
202218.7B18.7B18.9B18.7B
202118.9B19.6B19.4B18.8B
202017.4B16.9B17.1B18.2B
201917.0B17.1B17.3B17.4B
201813.5B14.7B16.0B17.1B
201712.3B12.2B12.1B12.3B
201612.2B12.3B12.5B12.4B
20158.5B9.4B10.3B11.2B
20148.2B8.3B8.4B8.5B
20137.8B7.9B8.1B8.2B
20127.6B7.7B7.7B7.8B
20117.2B7.3B7.6B7.6B
20107.2B7.2B7.1B7.1B
20096.9B7.0B7.0B7.1B
200806.6B6.9B6.9B
2007006.3B0
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index

Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022


Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.

S&P 500 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Becton Dickinson and Co

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Apr 04, 2024
neal shana carol
sold (taxes)
-
-
-1,921
evp and chief people officer
Mar 14, 2024
spoerel thomas j
sold
-67,197
238
-282
svp,controller&chief acct off
Mar 01, 2024
garrison michael david
sold (taxes)
-
-
-178
evp & president medical
Mar 01, 2024
spoerel thomas j
sold (taxes)
-
-
-36.00
svp,controller&chief acct off
Mar 01, 2024
ezell antoine c
sold (taxes)
-
-
-282
evp, president na & cmo
Jan 23, 2024
waldstreicher joanne
acquired
-
-
900
-
Jan 23, 2024
jones christopher ian montague
acquired
-
-
900
-
Jan 23, 2024
eckert r andrew
acquired
-
-
900
-
Jan 23, 2024
scott bertram l
acquired
-
-
900
-
Jan 23, 2024
ring timothy m
acquired
-
-
900
-

1–10 of 50

Which funds bought or sold BDX recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Apr 15, 2024
THOMPSON INVESTMENT MANAGEMENT, INC.
unchanged
-
214
14,600
-%
Apr 15, 2024
Capital Investment Advisors, LLC
reduced
-4.68
-14,345
428,176
0.01%
Apr 15, 2024
Wealthcare Advisory Partners LLC
reduced
-0.18
8,779
682,786
0.02%
Apr 15, 2024
DEFINED WEALTH MANAGEMENT, LLC
new
-
367,958
367,958
0.26%
Apr 15, 2024
FIRST CITIZENS BANK & TRUST CO
added
281
837,992
1,129,860
0.02%
Apr 15, 2024
EXCHANGE TRADED CONCEPTS, LLC
added
86.15
754,704
1,603,480
0.04%
Apr 15, 2024
Procyon Advisors, LLC
added
14.18
522,016
3,809,810
0.30%
Apr 15, 2024
Key Client Fiduciary Advisors, LLC
added
2.57
16,548
424,334
0.22%
Apr 15, 2024
St. Johns Investment Management Company, LLC
unchanged
-
3.00
139
-%
Apr 15, 2024
Security National Bank
added
18.26
16,839
100,960
0.01%

1–10 of 50

Are Funds Buying or Selling BDX?

Are funds buying BDX calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own BDX
No. of Funds

Unveiling Becton Dickinson and Co's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 16, 2024
price t rowe associates inc /md/
3.6%
10,391,519
SC 13G/A
Feb 14, 2024
price t rowe associates inc /md/
3.6%
10,391,519
SC 13G/A
Feb 13, 2024
vanguard group inc
9.02%
26,123,070
SC 13G/A
Jan 26, 2024
blackrock inc.
7.9%
22,774,866
SC 13G/A
Feb 14, 2023
price t rowe associates inc /md/
6.7%
18,962,386
SC 13G/A
Feb 09, 2023
vanguard group inc
8.94%
25,421,347
SC 13G/A
Feb 07, 2023
blackrock inc.
8.4%
23,781,609
SC 13G/A
Feb 14, 2022
price t rowe associates inc /md/
7.0%
20,016,331
SC 13G
Feb 09, 2022
vanguard group inc
8.48%
24,176,366
SC 13G/A
Feb 08, 2022
blackrock inc.
7.5%
21,348,508
SC 13G/A

Recent SEC filings of Becton Dickinson and Co

View All Filings
Date Filed Form Type Document
Apr 05, 2024
4
Insider Trading
Mar 15, 2024
4
Insider Trading
Mar 14, 2024
144
Notice of Insider Sale Intent
Mar 05, 2024
4
Insider Trading
Mar 05, 2024
4
Insider Trading
Mar 05, 2024
4
Insider Trading
Feb 27, 2024
8-K
Current Report
Feb 16, 2024
SC 13G/A
Major Ownership Report
Feb 14, 2024
SC 13G/A
Major Ownership Report
Feb 13, 2024
SC 13G/A
Major Ownership Report

Peers (Alternatives to Becton Dickinson and Co)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
189.6B
40.1B
-5.40% 4.53%
33.12
4.73
-8.12% -17.45%
66.7B
19.5B
-2.42% -9.87%
53.13
3.42
4.02% -22.04%
22.9B
3.9B
-2.94% -12.25%
51.49
5.93
3.42% 23.09%
20.1B
14.8B
-4.93% -7.94%
7.56
1.36
2.12% 209.17%
MID-CAP
9.2B
12.3B
-4.49% -14.03%
22
0.74
-2.44% -22.68%
9.2B
3.5B
-1.69% 15.70%
32.17
2.62
4.97% 18.89%
8.5B
2.7B
-12.27% -39.23%
-13.41
3.2
-4.68% 82.43%
6.4B
4.0B
-6.21% -24.72%
-47.49
1.61
1.10% 85.84%
3.4B
366.4M
-0.75% 15.36%
-565.58
9.37
33.86% 89.83%
2.3B
6.6B
-5.91% -4.69%
11.86
0.35
2.78% -0.87%
SMALL-CAP
1.3B
3.2B
-6.61% -18.37%
-1.88
0.4
7.73% -1066.14%
380.0M
166.7M
0.59% -11.05%
-4.6
2.28
6.67% -456.34%
260.4M
324.0M
21.04% -28.41%
-1.35
0.8
-3.19% -337.41%
48.2M
52.3M
-22.35% -53.67%
-2.57
0.92
17.61% 19.28%
3.8M
3.7M
-16.76% 269.23%
-0.31
1.01
5.77% 8.23%

Becton Dickinson and Co News

Latest updates
MarketBeat15 hours ago
Yahoo Finance12 Apr 202403:04 pm

Becton Dickinson and Co Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Revenue-7.5%4,7065,0874,8784,8214,5864,7614,6414,7504,7184,5764,6074,9075,3154,7843,8554,2534,2254,5844,3504,1954,160
Costs and Expenses-9.9%4,2674,7384,3294,1934,0014,2724,1044,1854,0274,3454,1144,4734,0744,0573,4973,8843,7244,4743,7254,0593,273
  S&GA Expenses6.6%1,2131,1381,1901,2051,1871,1831,1491,1921,1851,2541,2001,1481,1491,0599801,0251,1211,0941,0761,0891,073
  R&D Expenses3.2%290281306337313300315327314355330317291243262264270270282252258
EBITDA Margin-3.3%0.22*0.23*0.24*0.24*0.23*0.23*0.22*0.22*0.21*0.23*0.21*0.21*0.21*0.18*0.21*0.22*0.21*0.24*0.27*--
Interest Expenses-1.8%11111311911810210499.0097.0098.00112115124118123135134136141156171171
Income Taxes175.0%77.0028.0064.0068.00-28.0033.0031.0052.0032.00-24.00-28.006.00154-34.00-38.0017.00117-1649.00-17.00115
Earnings Before Taxes98.3%3591814715294813204214426002.003783051,157-428248200394-1.504603.00714
EBT Margin-7.9%0.08*0.09*0.09*0.09*0.09*0.09*0.08*0.08*0.07*0.09*0.07*0.07*0.06*0.02*0.05*0.06*0.05*0.07*0.09*--
Net Income160.2%2811084074605092883604546772655252991,00312828618327816345120.00599
Net Income Margin-15.9%0.06*0.08*0.09*0.09*0.09*0.09*0.09*0.10*0.09*0.11*0.10*0.09*0.09*0.05*0.05*0.06*0.05*0.07*0.05*--
Free Cashflow-28.3%7391,0318904.0019165842568.003473893219351,2877076602615401,013695--
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Assets-1.0%52,27452,78053,01754,39453,12952,93453,19954,78653,36353,86654,33354,92154,74854,01253,95953,51651,95251,76552,23352,59852,932
  Current Assets-6.0%8,1568,6768,5889,5878,1758,1419,54710,1528,3078,8389,53810,0009,5378,9698,8278,5556,4386,6646,7816,8446,941
    Cash Equivalents-16.7%1,1801,4169231,9817441,1592,7593,3202,0472,3923,2823,8983,4472,9172,9642,4396095905947671,042
  Inventory0.9%3,3043,2733,5883,6563,6043,2243,1633,2583,0352,7432,9472,8952,8142,7432,9452,7932,7602,5792,6292,6272,522
  Net PPE1.4%6,6476,5576,4746,3566,2476,0126,0056,4066,3846,0036,1646,1426,0965,9235,8415,6645,7825,6595,5505,4735,362
  Goodwill0.3%24,59724,52224,58424,78024,76324,62123,96824,09624,11623,88623,81423,77223,75823,60423,54923,41523,43523,37623,49823,51323,505
  Current Liabilities13.5%7,5406,6416,8787,3047,6257,8117,0806,6576,7356,6267,7495,3767,0215,8366,0678,7556,7265,6556,2377,1087,145
  Long Term Debt-4.4%14,09414,73814,92616,01014,26813,88614,68319916,36017,11015,7001,00526517,22450016,80916,94918,08118,01624917,817
    LT Debt, Non Current-4.4%14,09414,73814,92616,01014,26813,88614,68319916,36017,11015,7001,00526517,22450016,80916,94918,08118,01624917,817
Shareholder's Equity-1.8%25,33225,79625,93715,56319,59036524.0019,49524.0023.0024,13523.0036536519,22823.0012,93823.0023.0034724.00
  Retained Earnings0.0%15,54015,53515,69115,56315,38415,15715,08814,41614,23313,82613,82113,55713,52212,79112,91612,86812,93812,91312,99712,79213,018
  Additional Paid-In Capital0.1%19,74119,72019,68119,63919,59019,55319,51119,49519,43519,27219,28219,34119,30119,27019,22816,28816,32016,27016,22716,17716,174
Accumulated Depreciation3.3%7,2537,0217,0026,8486,6796,4026,3996,7886,6486,0906,4876,2776,1775,9965,8195,5985,6435,4695,4915,4025,223
Shares Outstanding-289-290284284-285285292-294298298-297279278-277276276
Float----70,253---74,866---70,616---62,360---67,279-
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations-35.5%8551,3251,0811853999736782905308415641,1881,5338798624837131,371932782245
  Share Based Compensation43.1%83.0058.0056.0056.0089.0049.0050.0053.0081.0047.0044.0055.0083.0043.0052.0059.0082.0053.0056.0059.0093.00
Cashflow From Investing-270.1%-233137-329-233-291-2,005-236-297-682-681-299-433-430-285-363-255-287-441-330-269299
Cashflow From Financing13.5%-862-997-1,7941,369-534-549-846986-327-1,142-1,271-301-592-1,20820.001,623-413-923-768-798-734
  Dividend Payments3.8%275265286282281270271270271259261264264253268253252247246246245
  Buy Backs-500----500---750-----------

BDX Income Statement

2023-12-31
Condensed Consolidated Statements of Income - USD ($)
$ in Millions
3 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]  
Revenues$ 4,706$ 4,586
Cost of products sold2,6792,453
Selling and administrative expense1,2131,187
Research and development expense290313
Integration and restructuring expense7544
Other operating expense, net113
Total Operating Costs and Expenses4,2674,001
Operating Income439585
Interest expense(111)(102)
Interest income346
Other expense, net(4)(8)
Income Before Income Taxes359481
Income tax provision (benefit)77(28)
Net Income281509
Preferred stock dividends0(23)
Net income applicable to common shareholders$ 281$ 486
Basic Earnings per Share (USD per share)$ 0.97$ 1.71
Diluted Earnings per Share (USD per share)0.961.70
Dividends per Common Share (USD per share)$ 0.95$ 0.91

BDX Balance Sheet

2023-12-31
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2023
Sep. 30, 2023
Current Assets:  
Cash and equivalents$ 1,180$ 1,416
Restricted cash5465
Short-term investments28
Trade receivables, net2,2672,534
Inventories:  
Materials776714
Work in process368381
Finished products2,1602,178
Inventories3,3043,273
Prepaid expenses and other1,3491,380
Total Current Assets8,1568,676
Property, Plant and Equipment13,89913,578
Less allowances for depreciation and amortization7,2537,021
Property, Plant and Equipment, Net6,6476,557
Goodwill24,59724,522
Developed Technology, Net7,8078,058
Customer Relationships, Net2,2522,338
Other Intangibles, Net555552
Other Assets2,2592,078
Total Assets52,27452,780
Current Liabilities:  
Current debt obligations2,0161,141
Payables, accrued expenses and other current liabilities5,5245,500
Total Current Liabilities7,5406,641
Long-Term Debt14,09414,738
Long-Term Employee Benefit Obligations8941,023
Deferred Income Taxes and Other Liabilities4,4144,582
Commitments and Contingencies (See Note 5)
Shareholders’ Equity  
Common stock — $1 par value; authorized — 640,000,000 shares; issued — 370,594,401 shares in December 31, 2023 and September 30, 2023371371
Capital in excess of par value19,74119,720
Retained earnings15,54015,535
Deferred compensation2424
Treasury stock(8,828)(8,305)
Accumulated other comprehensive loss(1,515)(1,548)
Total Shareholders’ Equity25,33225,796
Total Liabilities and Shareholders’ Equity$ 52,274$ 52,780
BDX
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.
 CEO
 WEBSITEbd.com
 INDUSTRYMedical Instruments & Supplies
 EMPLOYEES65535

Becton Dickinson and Co Frequently Asked Questions


What is the ticker symbol for Becton Dickinson and Co? What does BDX stand for in stocks?

BDX is the stock ticker symbol of Becton Dickinson and Co. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Becton Dickinson and Co (BDX)?

As of Tue Apr 16 2024, market cap of Becton Dickinson and Co is 66.73 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of BDX stock?

You can check BDX's fair value in chart for subscribers.

What is the fair value of BDX stock?

You can check BDX's fair value in chart for subscribers. The fair value of Becton Dickinson and Co is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Becton Dickinson and Co is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for BDX so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Becton Dickinson and Co a good stock to buy?

The fair value guage provides a quick view whether BDX is over valued or under valued. Whether Becton Dickinson and Co is cheap or expensive depends on the assumptions which impact Becton Dickinson and Co's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for BDX.

What is Becton Dickinson and Co's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Apr 16 2024, BDX's PE ratio (Price to Earnings) is 53.13 and Price to Sales (PS) ratio is 3.42. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. BDX PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Becton Dickinson and Co's stock?

In the past 10 years, Becton Dickinson and Co has provided 0.091 (multiply by 100 for percentage) rate of return.